Atezolizumab and motixafortide, cobimetinib or simlukafusp alfa in pretreated advanced pancreatic cancer: phase I/IIb MORPHEUS-PDAC umbrella study

Gulam A Manji, Vincent Chung, Do-Youn Oh, Jill Lacy, Charles D Lopez, Mariano Ponz-Sarvisé, Teresa Macarulla, Roby Thomas, Ben George, Angela Alistar, Jens T Siveke, Yun Xu, Janet Lau, Edward Cha, Kyu-Pyo Kim, Eileen M O’Reilly

Open source

DOI: 10.1093/oncolo/oyag023
Published: 2026-02-25
Container: The Oncologist
Publisher: Oxford University Press (OUP)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/oncolo/oyag023,
  title = {Atezolizumab and motixafortide, cobimetinib or simlukafusp alfa in pretreated advanced pancreatic cancer: phase I/IIb MORPHEUS-PDAC umbrella study},
  author = {Gulam A Manji and Vincent Chung and Do-Youn Oh and Jill Lacy and Charles D Lopez and Mariano Ponz-Sarvisé and Teresa Macarulla and Roby Thomas and Ben George and Angela Alistar and Jens T Siveke and Yun Xu and Janet Lau and Edward Cha and Kyu-Pyo Kim and Eileen M O’Reilly},
  year = {2026},
  journal = {The Oncologist},
  doi = {10.1093/oncolo/oyag023},
  url = {https://doi.org/10.1093/oncolo/oyag023}
}

RIS

TY  - JOUR
TI  - Atezolizumab and motixafortide, cobimetinib or simlukafusp alfa in pretreated advanced pancreatic cancer: phase I/IIb MORPHEUS-PDAC umbrella study
AU  - Gulam A Manji
AU  - Vincent Chung
AU  - Do-Youn Oh
AU  - Jill Lacy
AU  - Charles D Lopez
AU  - Mariano Ponz-Sarvisé
AU  - Teresa Macarulla
AU  - Roby Thomas
AU  - Ben George
AU  - Angela Alistar
AU  - Jens T Siveke
AU  - Yun Xu
AU  - Janet Lau
AU  - Edward Cha
AU  - Kyu-Pyo Kim
AU  - Eileen M O’Reilly
PY  - 2026
JO  - The Oncologist
DO  - 10.1093/oncolo/oyag023
UR  - https://doi.org/10.1093/oncolo/oyag023
ER  -

APA

Manji, G. A., Chung, V., Oh, D., Lacy, J., Lopez, C. D., Ponz-Sarvisé, M., Macarulla, T., Thomas, R., George, B., Alistar, A., Siveke, J. T., Xu, Y., Lau, J., Cha, E., Kim, K., & O’Reilly, E. M. (2026). Atezolizumab and motixafortide, cobimetinib or simlukafusp alfa in pretreated advanced pancreatic cancer: phase I/IIb MORPHEUS-PDAC umbrella study. The Oncologist. https://doi.org/10.1093/oncolo/oyag023

Source records

crossref · retrieved 2026-09-27T00:08:01.116Z